Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewDAPT is an Ancillary Material Grade version of DAPT (Cat. No. 2634). Suitable for use as an ancillary reagent in the further manufacturing of cell therapies.
For more information about how DAPT may be used, see our protocols: Accelerated Induction of Cortical Neurons from hiPSCs, Human iPSC-derived Myoblasts, Generating Midbrain Dopaminergic Neurons from hPSCs.
Find out more about our Ancillary Material Grade product range.
分子量 | 432.46 |
公式 | C23H26F2N2O4 |
储存 | Store at 2-8°C |
纯度 | ≥99% |
CAS Number | 208255-80-5 |
InChI Key | DWJXYEABWRJFSP-PVCZSOGJSA-N |
Smiles | CC(C)(C)OC([C@H](C1=CC=CC=C1)NC([C@H](C)NC(CC2=CC(F)=CC(F)=C2)=O)=O)=O |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
关键词: DAPT, DAPT supplier, Ancillary, material, grade, reagents, raw, materials, stem, cell, therapy, therapies, regenerative, medicine, gamma, secretase, inhibitor, inhibitors, GMP, Material, Grade, Small, Molecules, TB2634-RMU, Tocris Bioscience
目前没有该产品的评论。 Be the first to review DAPT and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
The following protocols feature additional information for the use of DAPT (Cat. No. TB2634-RMU).
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。
Written by Kirsty E. Clarke, Victoria B. Christie, Andy Whiting and Stefan A. Przyborski, this review provides an overview of the use of small molecules in the control of stem cell growth and differentiation. Key signaling pathways are highlighted, and the regulation of ES cell self-renewal and somatic cell reprogramming is discussed. Compounds available from Tocris are listed.
Stem cells have potential as a source of cells and tissues for research and treatment of disease. This poster summarizes some key protocols demonstrating the use of small molecules across the stem cell workflow, from reprogramming, through self-renewal, storage and differentiation to verification. Advantages of using small molecules are also highlighted.